CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas (vol 13, 3739, 2022)

被引：0

作者：

Niborski, Leticia Laura ^{[1
,2
,3
]}

Gueguen, Paul ^{[1
,2
]}

Ye, Mengliang ^{[1
,2
]}

Thiolat, Allan ^{[4
,5
]}

Ramos, Rodrigo Nalio ^{[1
,2
,3
]}

Caudana, Pamela ^{[1
,2
,3
]}

Denizeau, Jordan ^{[1
,2
,3
]}

Colombeau, Ludovic ^{[6
]}

Rodriguez, Raphael ^{[6
]}

Goudot, Christel ^{[1
,2
]}

Luccarini, Jean-Michel ^{[7
]}

Soude, Anne ^{[7
]}

Bournique, Bruno ^{[7
]}

Broqua, Pierre ^{[7
]}

Pace, Luigia ^{[1
,2
]}

Baulande, Sylvain ^{[8
]}

Sedlik, Christine ^{[1
,2
,3
]}

Quivy, Jean-Pierre ^{[1
,9
,10
]}

Almouzni, Genevieve ^{[1
,9
,10
]}

Cohen, Jose L. ^{[4
,5
]}

Zueva, Elina ^{[1
,2
]}

Waterfall, Joshua J. ^{[1
,3
,11
]}

Amigorena, Sebastian ^{[1
,2
]}

Piaggio, Eliane ^{[1
,2
,3
]}

机构：

[1] PSL Res Univ, Inst Curie, F-75005 Paris, France

[2] INSERM U932, F-75005 Paris, France

[3] Inst Curie, Translat Res Dept, F-75005 Paris, France

[4] Univ Paris Est Creteil Val Marne, Univ Paris Est, UMR S955, Creteil, France

[5] INSERM, Equipe 21, U955, Creteil, France

[6] PSL Res Univ, CNRS UMR3666, Inst Curie, INSERM UMR3666,Chem Biol Canc,Equipe Labellisee L, Paris, France

[7] Inventiva, 50 Rue Dijon, F-21121 Daix, France

[8] Inst Curie Res Ctr, Inst Curie Genom Excellence ICGex Platform, Paris, France

[9] PSL Res Univ, CNRS, Inst Curie, Equipe Labellisee Ligue Canc,UMR3664, Paris, France

[10] Sorbonne Univ, UPMC Univ Paris 06, CNRS, UMR3664, F-7005 Paris, France

[11] INSERM U830, F-75005 Paris, France

来源：

NATURE COMMUNICATIONS | 2023年 / 14卷 / 01期

关键词：

D O I：

10.1038/s41467-023-38931-6

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页数：1

共 50 条

[21] RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1
Ming Zhao
Xiaoyan Wu
Qing Zhang
Shuangyan Luo
Gongping Liang
Yuwen Su
Yixin Tan
Qianjin Lu
Arthritis Research & Therapy, 12
[22] RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1
Zhao, Ming
Wu, Xiaoyan
Zhang, Qing
Luo, Shuangyan
Liang, Gongping
Su, Yuwen
Tan, Yixin
Lu, Qianjin
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (06)
[23] The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response
Bernhard, Wendy
Barreto, Kris
Saunders, Amy
Dahabieh, Matthew S.
Johnson, Pauline
Sadowski, Ivan
FEBS LETTERS, 2011, 585 (22): : 3549 - 3554
[24] Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+T Cell Function and Anti-tumor Immunity
Shen, Shanling
Sckisel, Gail
Sahoo, Anupama
Lalani, Almin
Den Otter, Doug
Pearson, Josh
DeVoss, Jason
Cheng, Jay
Casey, Stephanie C.
Case, Ryan
Yang, Melissa
Low, Ray
Daris, Mark
Fan, Bin
Agrawal, Neeraj J.
Ali, Khaled
FRONTIERS IN IMMUNOLOGY, 2020, 11
[25] ZNF683 (Hobit) Marks a CD8+T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome
Lemvigh, Camilla K.
Parry, Erin Michelle
Deng, Stephanie L.
Dangle, Nathan J.
Ruthen, Neil
Knisbacher, Binyamin A.
Broseus, Julien
Hergalant, Sebastien
Guieze, Romain
Li, Shuqiang
Yin, Shanye
Huang, Teddy
Livak, Kenneth J.
Getz, Gad
Neuberg, Donna S.
Feugier, Pierre
Kharchenko, Peter
Wierda, William G.
Olsen, Lars Ronn
Jain, Nitin
Wu, Catherine J.
BLOOD, 2022, 140 : 1807 - 1808
[26] Altered PD-1-PD-L1 Pathway in CD8+T cells of (New Zealand Black x New Zealand White) BWF1 Mice with Anti-PD-1 antibody
Wong, Maida
Hahn, Bevra
La Cava, Antonio
Singh, Ram P.
JOURNAL OF IMMUNOLOGY, 2009, 182
[27] Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+T cells via pharmacological activation of FOXO3
Chung, Young Min
Khan, Pragya P.
Wang, Hong
Tsai, Wen-Bin
Qiao, Yanli
Yu, Bo
Larrick, James W.
Hu, Mickey C-T
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (12)
[28] Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma
Zhu, Qian
Qiao, Guoliang
Huang, Lefu
Xu, Chang
Guo, Deliang
Wang, Shuo
Zhao, Jing
Song, Yuguang
Liu, Bing
Chen, Zheng
Yang, Zhiyong
Yuan, Yufeng
FRONTIERS IN ONCOLOGY, 2022, 12
[29] PD-1 modulates CD8+T cell function in prostate tumor microenvironment
Stokes, James
Berry, Eric
Singh, Rajesh
Manne, Upender
Mishra, Manoj K.
CANCER RESEARCH, 2019, 79 (13)
[30] CD39 T Cells With Low PD-1 Expression are Markers for Durable Immunotherapy Response to Anti-PD-1 in Murine Glioblastoma
Choi, John
Pant, Ayush
Kim, Young-Hoon
Routkevitch, Denis
Jackson, Christopher Mitchell
Jackson, Christina
Kim, Lily H.
Lim, Michael
NEUROSURGERY, 2023, 69 : 117 - 118

← 1 2 3 4 5 →